19 related articles for article (PubMed ID: 3464432)
1. Asset mapping score analysis: a novel public health research methodology applied to maternal and child health resources in New Orleans.
Healy J; Ramirez S; Knapp M; Johnson C
Arch Public Health; 2023 Feb; 81(1):33. PubMed ID: 36855065
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and resistance to chemotherapy in acute leukemia: correlation with in vitro drug uptake and lack of potentiation by verapamil.
Andersson BS; Beran M; Stuckey SE; McCredie KB; Mavligit GM
Med Oncol Tumor Pharmacother; 1987; 4(1):17-21. PubMed ID: 3600053
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines.
Snow K; Judd W
Br J Cancer; 1991 Jan; 63(1):17-28. PubMed ID: 1989661
[TBL] [Abstract][Full Text] [Related]
4. Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.
Zwelling LA; Michaels S; Erickson LC; Ungerleider RS; Nichols M; Kohn KW
Biochemistry; 1981 Nov; 20(23):6553-63. PubMed ID: 6895473
[TBL] [Abstract][Full Text] [Related]
5. The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).
Bakic M; Beran M; Andersson BS; Silberman L; Estey E; Zwelling LA
Biochem Biophys Res Commun; 1986 Jan; 134(2):638-45. PubMed ID: 3004458
[TBL] [Abstract][Full Text] [Related]
6. Cooperative sequestration of m-AMSA in L1210 cells.
Zwelling LA; Kerrigan D; Michaels S; Kohn KW
Biochem Pharmacol; 1982 Oct; 31(20):3269-77. PubMed ID: 6897359
[TBL] [Abstract][Full Text] [Related]
7. Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions.
Zwelling LA; Mayes J; Hinds M; Chan D; Altschuler E; Carroll B; Parker E; Deisseroth K; Radcliffe A; Seligman M
Biochemistry; 1991 Apr; 30(16):4048-55. PubMed ID: 1850298
[TBL] [Abstract][Full Text] [Related]
8. Effect of 1-beta-D-arabinofuranosylcytosine (ara-C) on nuclear topoisomerase II activity and on the DNA cleavage and cytotoxicity produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and etoposide in m-AMSA-sensitive and -resistant human leukemia cells.
Bakic M; Chan D; Andersson BS; Beran M; Silberman L; Estey E; Ricketts L; Zwelling LA
Biochem Pharmacol; 1987 Dec; 36(23):4067-77. PubMed ID: 2825713
[TBL] [Abstract][Full Text] [Related]
9. Analysis of nuclear m-AMSA content by DNA fluorochrome competition.
Andersson BS; Beran M; Barlogie B; Van NT; McCredie KB
Eur J Cancer Clin Oncol; 1986 Jul; 22(7):883-9. PubMed ID: 3464432
[TBL] [Abstract][Full Text] [Related]
10. Intercalator-induced, topoisomerase II-mediated DNA cleavage and its modification by antineoplastic antimetabolites.
Zwelling LA; Silberman L; Estey E
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1041-7. PubMed ID: 2427489
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
